167 related articles for article (PubMed ID: 24453469)
61. Individual and partner risk factors associated with abnormal cervical cytology among women in HIV-discordant relationships.
Soh J; Rositch AF; Koutsky L; Guthrie BL; Choi RY; Bosire RK; Gatuguta A; Smith JS; Kiarie J; Lohman-Payne B; Farquhar C
Int J STD AIDS; 2014 Apr; 25(5):315-24. PubMed ID: 24047885
[TBL] [Abstract][Full Text] [Related]
62. Highly active antiretroviral therapy (HAART) and outcome of cervical lesions and high-risk HPV in women living with HIV (WLHIV): A systematic review and meta-analysis.
Gupta R; Mariano LC; Singh S; Gupta S
Eur J Obstet Gynecol Reprod Biol; 2022 Nov; 278():153-158. PubMed ID: 36194939
[TBL] [Abstract][Full Text] [Related]
63. [Cervical disease in postmenopausal HIV-1-infected women].
Ceccaldi PF; Ferreira C; Coussy F; Mechler C; Meier F; Crenn-Hebert C; Mandelbrot L
J Gynecol Obstet Biol Reprod (Paris); 2010 Oct; 39(6):466-70. PubMed ID: 20692113
[TBL] [Abstract][Full Text] [Related]
64. Cryotherapy Reduces Progression of Cervical Intraepithelial Neoplasia Grade 1 in South African HIV-Infected Women: A Randomized, Controlled Trial.
Firnhaber C; Swarts A; Goeieman B; Rakhombe N; Mulongo M; Williamson AL; Michelow P; Ramotshela S; Faesen M; Levin S; Wilkin T
J Acquir Immune Defic Syndr; 2017 Dec; 76(5):532-538. PubMed ID: 28902073
[TBL] [Abstract][Full Text] [Related]
65. The impact of HAART on HPV-related cervical disease.
Adler DH
Curr HIV Res; 2010 Oct; 8(7):493-7. PubMed ID: 20946095
[TBL] [Abstract][Full Text] [Related]
66. Prevalence and risk factors for cervical intraepithelial neoplasia among HIV-infected women.
Teixeira NC; Araújo AC; Correa CM; Lodi CT; Lima MI; Carvalho Nde O; Castillo DM; Melo VH
Braz J Infect Dis; 2012; 16(2):164-9. PubMed ID: 22552459
[TBL] [Abstract][Full Text] [Related]
67. Human papillomavirus infection and associated factors for cervical intraepithelial neoplasia in women living with HIV in China: a cross-sectional study.
Wang Q; Ma X; Zhang X; Ong JJ; Jing J; Zhang L; Wang LH
Sex Transm Infect; 2019 Mar; 95(2):140-144. PubMed ID: 30337414
[TBL] [Abstract][Full Text] [Related]
68. Effect of excisional therapy and highly active antiretroviral therapy on cervical intraepithelial neoplasia in women infected with human immunodeficiency virus.
Robinson WR; Hamilton CA; Michaels SH; Kissinger P
Am J Obstet Gynecol; 2001 Mar; 184(4):538-43. PubMed ID: 11262450
[TBL] [Abstract][Full Text] [Related]
69. HIV-1, HIV-2, human papillomavirus infection and cervical neoplasia in high-risk African women.
Langley CL; Benga-De E; Critchlow CW; Ndoye I; Mbengue-Ly MD; Kuypers J; Woto-Gaye G; Mboup S; Bergeron C; Holmes KK; Kiviat NB
AIDS; 1996 Apr; 10(4):413-7. PubMed ID: 8728046
[TBL] [Abstract][Full Text] [Related]
70. [Feasibility of cervical smear in HIV-positive women living in Chad].
Mortier E; Doudéadoum N; Némian F; Gaulier A; Kemian M
Bull Soc Pathol Exot; 2016 Aug; 109(3):180-4. PubMed ID: 27299910
[TBL] [Abstract][Full Text] [Related]
71. Factors associated with recurrence of cervical intraepithelial neoplasia 2+ after treatment among HIV-infected women in Western Kenya.
Huchko MJ; Leslie H; Maloba M; Bukusi EA; Cohen CR
J Acquir Immune Defic Syndr; 2014 Jun; 66(2):188-92. PubMed ID: 24662299
[TBL] [Abstract][Full Text] [Related]
72. Screening for human papillomavirus, cervical cytological abnormalities and associated risk factors in HIV-positive and HIV-negative women in Rwanda.
Mukanyangezi MF; Sengpiel V; Manzi O; Tobin G; Rulisa S; Bienvenu E; Giglio D
HIV Med; 2018 Feb; 19(2):152-166. PubMed ID: 29210158
[TBL] [Abstract][Full Text] [Related]
73. HIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active antiretroviral therapy.
Sterling TR; Chaisson RE; Moore RD
AIDS; 2001 Nov; 15(17):2251-7. PubMed ID: 11698698
[TBL] [Abstract][Full Text] [Related]
74. Prevalence and correlates of cervical squamous intraepithelial lesions among HIV-infected and uninfected women in Central Kenya.
Njagi SK; Ngure K; Mwaniki L; Kiptoo M; Mugo NR
Pan Afr Med J; 2021; 39():44. PubMed ID: 34422167
[TBL] [Abstract][Full Text] [Related]
75. Evaluation of the effectiveness of highly active antiretroviral therapy in persons with human immunodeficiency virus using biomarker-based equivalence of disease progression.
Jacobson LP; Li R; Phair J; Margolick JB; Rinaldo CR; Detels R; Muñoz A
Am J Epidemiol; 2002 Apr; 155(8):760-70. PubMed ID: 11943695
[TBL] [Abstract][Full Text] [Related]
76. HIV-positive women have higher risk of human papilloma virus infection, precancerous lesions, and cervical cancer.
Liu G; Sharma M; Tan N; Barnabas RV
AIDS; 2018 Mar; 32(6):795-808. PubMed ID: 29369827
[TBL] [Abstract][Full Text] [Related]
77. Cervical disease and cancer in HIV positive women. Recommendations for screening and diagnosis.
Heard I
Med Wieku Rozwoj; 2003; 7(4 Pt 1):479-85. PubMed ID: 15010558
[TBL] [Abstract][Full Text] [Related]
78. Prevention of cervical cancer in women with HIV.
Heard I
Curr Opin HIV AIDS; 2009 Jan; 4(1):68-73. PubMed ID: 19339941
[TBL] [Abstract][Full Text] [Related]
79. Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors, and validity of Papanicolaou smears. New York Cervical Disease Study.
Wright TC; Ellerbrock TV; Chiasson MA; Van Devanter N; Sun XW
Obstet Gynecol; 1994 Oct; 84(4):591-7. PubMed ID: 8090399
[TBL] [Abstract][Full Text] [Related]
80. Cervical dysplasia in women infected with the human immunodeficiency virus (HIV): a correlation with HIV viral load and CD4+ count.
Davis AT; Chakraborty H; Flowers L; Mosunjac MB
Gynecol Oncol; 2001 Mar; 80(3):350-4. PubMed ID: 11263930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
